Related Experiment Video
Updated: May 22, 2026
07:25
Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans
Published on: December 9, 2022
Omega 3 fatty acids in the elderly.
Natalia Ubeda1, María Achón, Gregorio Varela-Moreiras
1Departamento de Ciencias Farmacéuticas y de Alimentación, Facultad de Farmacia, Universidad CEU San Pablo, Urb. Montepríncipe, Ctra. Boadilla km. 5,3, 28668, Boadilla del Monte (Madrid), Spain.
The British Journal of Nutrition
|May 18, 2012
Summary
Omega-3 fatty acids may support healthy aging, but research is limited. More studies are needed to confirm their benefits for older adults
Area of Science:
- Gerontology and Nutritional Science.
Background:
- Global population is aging, increasing the need for strategies to maintain quality of life in older adults.
- Omega-3 fatty acids are recognized for their potential role in preventing age-related conditions.
- Understanding the impact of omega-3s on normal aging is crucial for public health.
Purpose of the Study:
- To review the effects of omega-3 fatty acids on normal aging in adults aged 65 and older.
- To assess the impact of omega-3s on nutritional status, cognition, bone health, muscle tonus, and general health.
- To identify gaps in current research regarding omega-3s and healthy aging.
Main Methods:
- A literature search identified 685 citations on omega-3 fatty acids and normal aging.
- Forty-two full-text papers were assessed for eligibility.
- Thirty-six studies were included in the final review.
Main Results:
- The review found a limited number of studies examining omega-3s' effects on normal aging.
- Methodological limitations were noted in the existing research.
- Insufficient evidence exists to draw definitive conclusions.
Conclusions:
- Current evidence is insufficient to establish the effects of omega-3 fatty acids on aging metabolism and quality of life in the absence of pathology.
- Further high-quality research is required to confirm the benefits of omega-3s for healthy aging.
- The elderly population, despite its size, is underrepresented in studies on omega-3s and normal aging.
Related Concept Videos
03:38Structure of Lipids
Lipids include a diverse group of compounds that are largely nonpolar in nature. This is because they are hydrocarbons that include mostly nonpolar carbon-carbon or carbon-hydrogen bonds. Non-polar molecules are hydrophobic (“water fearing”), or insoluble in water. Lipids perform many different functions in a cell. Cells store energy for long-term use in the form of fats. Lipids also provide insulation from the environment for plants and animals. For example, they help keep aquatic birds and...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...